| Product Code: ETC13309935 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 & 2031F |
3.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, 2021 - 2031 |
6.1 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Endoscope, 2021 - 2031 |
6.1.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Mechanical endoscopic equipment, 2021 - 2031 |
6.1.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Visualization and documentation systems, 2021 - 2031 |
6.1.5 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Accessories, 2020 - 2028 |
6.1.6 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Other endoscopy equipment , 2020 - 2028 |
6.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Gastric balloon, 2021 - 2031 |
6.2.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Aspiration therapy, 2021 - 2031 |
6.2.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Endoscopic sleeve gastroplasty, 2021 - 2031 |
6.2.5 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Gastric injection, 2021 - 2031 |
6.2.6 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Lap band surgery , 2020 - 2028 |
6.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Obesity , 2021 - 2031 |
6.3.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Type II Diabetes , 2021 - 2031 |
6.3.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2021 - 2031 |
7 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.1 United States (US) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.3 Rest of North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
7.3.1 United States (US) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.3.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.3.3 Rest of North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.1 United States (US) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.3 Rest of North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
9 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Export/Import By Countries Assessment |
10 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
10.1 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
11 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
11.1 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2022 |
11.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here